Home › Interstitial Lung Diseases › Texas › Houston
Interstitial Lung Diseases clinical trials in Houston, TX
12 studies for Interstitial Lung Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RecruitingPhase 3
- Baylor College of Medicine, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Houston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- Baylor College of Medicine, Houston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Houston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Houston Methodist, Houston
- University of Texas Health Science Center at Houston, Houston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Baylor College of Medicine, Houston
- Houston Methodist Lung Center, Houston
- The University of Texas Health Science Center At Houston, Houston
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Houston Methodist Hospital, Houston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- Houston Methodist Outpatient Center, Houston
- The University of Texas Health Science Center at Houston, McGovern Medical School, Houston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
RecruitingObservational study
- Baylor College of Medicine/Texas Children'S Hospital, Houston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Houston
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Kansas City, KS13 studies
- Durham, NC13 studies
- Charleston, SC13 studies
- Chicago, IL12 studies
- Ann Arbor, MI11 studies
- Aurora, CO11 studies
- Salt Lake City, UT9 studies
- Phoenix, AZ9 studies
- Boston, MA9 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.